23 April 2020 - Preparations would help make doses rapidly if testing pans out, but companies risk large outlays if the research doesn’t succeed.
Drug makers are reconfiguring manufacturing plants and hiring hundreds of new workers to be ready to make coronavirus drugs and vaccines should they prove in testing to be effective in fighting off the virus.
Johnson & Johnson, Pfizer and other companies are gearing up so they can make hundreds of millions of doses of coronavirus pills and shots as quickly as possible if studies support their worth.